Network based biomarkers in Alzheimer's disease: review and future directions

By 2050 it is estimated that the number of worldwide Alzheimer’s (AD) patients will quadruple from the current number of 36 million people. To date, no single test, prior to postmortem examination, can confirm that a person suffers from AD. Therefore, there is a strong need for accurate and sensitiv...

Full description

Bibliographic Details
Main Authors: Jaime eGomez-Ramirez, Jinglong eWu
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-02-01
Series:Frontiers in Aging Neuroscience
Subjects:
AD
Online Access:http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00012/full